SMTL ID : 3d2t.1

Human transthyretin (ttr) complexed with diflunisal

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 1.85 Å

Oligo State

homo-tetramer

Ligands

4 x 1FL: 5-(2,4-DIFLUOROPHENYL)-2-HYDROXY-BENZOIC ACID(Non-covalent)

1FL.1: 14 residues within 4Å: Chain A: K.15, L.17, A.108, L.110, S.117, T.119, V.121 Chain C: K.15, L.17, A.108, A.109, L.110, S.117 Ligands: 1FL.3 8 PLIP interactions: 3 interactions with chain A, 5 interactions with chain C Hydrophobic interactions: A:A.108, A:V.121, C:L.17, C:L.17, C:L.110, C:L.110 Salt bridges: A:K.15, C:K.15 1FL.2: 11 residues within 4Å: Chain B: K.15, A.108, L.110, T.119, V.121 Chain D: K.15, L.17, A.108, L.110, S.117 Ligands: 1FL.4 8 PLIP interactions: 4 interactions with chain B, 4 interactions with chain D Hydrophobic interactions: B:A.108, B:V.121, D:L.17, D:L.110, D:L.110 Water bridges: B:K.15 Salt bridges: B:K.15, D:K.15 1FL.3: 14 residues within 4Å: Chain A: K.15, L.17, A.108, A.109, L.110, S.117 Chain C: K.15, L.17, A.108, L.110, S.117, T.119, V.121 Ligands: 1FL.1 8 PLIP interactions: 5 interactions with chain A, 3 interactions with chain C Hydrophobic interactions: A:L.17, A:L.17, A:L.110, A:L.110, C:A.108, C:V.121 Salt bridges: A:K.15, C:K.15 1FL.4: 11 residues within 4Å: Chain B: K.15, L.17, A.108, L.110, S.117 Chain D: K.15, A.108, L.110, T.119, V.121 Ligands: 1FL.2 8 PLIP interactions: 4 interactions with chain B, 4 interactions with chain D Hydrophobic interactions: B:L.17, B:L.110, B:L.110, D:A.108, D:V.121 Salt bridges: B:K.15, D:K.15 Water bridges: D:K.15

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Adamski-Werner, S.L. et al., Diflunisal analogues stabilize the native state of transthyretin. Potent inhibition of amyloidogenesis. J.Med.Chem. (2004)

Release Date

2008-05-20

Peptides

Transthyretin: ABCD

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

B
B

C
A

D
B

Transthyretin

Related Entries With Identical Sequence